Shots: Presage and BMS enter into a research collaboration to assess early stage oncology targets in P-0 studies by evaluating patients’ unique responses to micro doses of multiple cancer therapies […]readmore
Tags : Presage
Shots: Presage utilizes its CIVO intratumoral microdosing platform to evaluate Celgene’s early stage products in P-0 trial The collaboration follows safety & feasibility of CIVO in sarcoma patients, a clinical […]readmore